Company Filing History:
Years Active: 1976
Title: Albert Langemann: Innovator in Cytostatic Agents
Introduction
Albert Langemann is a notable inventor based in Binningen, Switzerland. He has made significant contributions to the field of chemistry, particularly in the development of compounds that serve as cytostatic agents. His work has implications for medical treatments and showcases the importance of innovation in pharmaceuticals.
Latest Patents
Langemann holds a patent for Methylhydrazinomethyl-substituted benzoic acid amides. This patent describes benzene-ring substituted (2-methylhydrazino)methylbenzene compounds and their intermediates. These compounds are particularly useful as cytostatic agents, which are critical in the treatment of various cancers.
Career Highlights
Throughout his career, Langemann has been associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work there has allowed him to focus on innovative solutions that address significant health challenges. With a patent portfolio that includes 1 patent, he has established himself as a key figure in his field.
Collaborations
Langemann has collaborated with esteemed colleagues such as Werner Bollag and Hugo Gutmann. These partnerships have fostered an environment of innovation and have contributed to the advancement of research in cytostatic agents.
Conclusion
Albert Langemann's contributions to the field of chemistry and pharmaceuticals highlight the vital role of inventors in advancing medical science. His work continues to impact the development of effective treatments for cancer, showcasing the importance of innovation in healthcare.